Skip to main content
SpringerLink
Log in

The MEN1 gene and associated diseases: An update

  • Review
  • Published:
Endocrine Pathology Aims and scope Submit manuscript

Abstract

Heterozygous germline mutations of the tumor suppressor gene MEN1 are responsible for multiple endocrine neoplasia type 1 (MEN1), a dominantly inherited familial cancer syndrome characterized by the combined occurrence of pituitary, parathyroid, and enteropancreatic tumors. Various types of mutations likely causing loss of the gene function have been identified throughout the entire gene region in patients with MEN1 and related disorders including a small fraction of familial isolated hyperparathyroidism (FIHP). Neither mutation hot spot nor phenotype-genotype correlation has been established in classical MEN1, although some missense mutations may be specifically associated with a phenotype of FIHP. Familial isolated pituitary tumor and atypical familial MEN1 consisting of only pituitary tumor and hyperparathyroidism usually lack germline MEN1 mutations, suggesting that these familial endocrine tumor syndromes are genetic entities distinct from MEN1. DNA test for MEN1 germline mutations is a robust tool for diagnosis of predisposition to MEN1, and will be useful for the counseling and management of patients and their families. In this review, we will summarize the most recent findings on the MEN1 gene, focusing primarily on germline mutations and associated diseases.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Carty SE, Helm AK, Amico JA, et al. The variable penetrance and spectrum of manifestations of multiple endocrine neoplasia type 1. Surgery 124:1106–1114, 1998.

    Article  PubMed  CAS  Google Scholar 

  2. Gardner DG. Recent advances in multiple endocrine neoplasia syndromes. Adv Int Med 42:597–627, 1997.

    CAS  Google Scholar 

  3. Trump D, Farren B, Wooding C, et al. Clinical studies of multiple endocrine neoplasia type 1 (MEN1). Q J Med 89:653–669, 1996.

    CAS  Google Scholar 

  4. Wermer P. Genetic aspects of adenomatosis of endocrine glands. Am J Med 16:363–371, 1954.

    Article  PubMed  CAS  Google Scholar 

  5. Darling TN, Skarulis MC, Steinberg SM, Marx SJ, Spiegel AM, Turner M. Multiple facial angiofibromas and collagenomas in patients with multiple endocrine neoplasia type 1. Arch Dermatol 133:853–857, 1997.

    Article  PubMed  CAS  Google Scholar 

  6. Veldhuis JD, Norton JA, Wells SA Jr, Vinik AI, Perry RR. Surgical versus medical management of multiple endocrine neoplasia (MEN) type I. J Clin Endocrinol Metab 82:357–364, 1997.

    Article  PubMed  CAS  Google Scholar 

  7. Debelenko LV, Emmert-Buck MR, Manickam P, et al. Haplotype analysis defines a minimal interval for the multiple endocrine neoplasia type 1 (MEN1) gene. Cancer Res 57:1039–1042, 1997.

    PubMed  CAS  Google Scholar 

  8. Emmert-Buck MR, Lubensky IA, Dong Q, et al. Localization of the multiple endocrine neoplasia type I (MEN1) gene based on tumor loss of heterozygosity analysis. Cancer Res 57:1855–1858, 1997.

    PubMed  CAS  Google Scholar 

  9. Larsson C, Skogseid B, Öberg K, Nakamura Y, Nordenskjöld M. Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma. Nature 332:85–87, 1988.

    Article  PubMed  CAS  Google Scholar 

  10. Thakker RV, Bouloux P, Wooding C, et al. Association of parathyroid tumors in multiple endocrine neoplasia type 1 with loss of alleles on chromosome 11. N Eng J Med 321:218–224, 1989.

    Article  CAS  Google Scholar 

  11. Chandrasekharappa SC, Guru SC, Manickam P, et al. Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science 276:404–407, 1997.

    Article  PubMed  CAS  Google Scholar 

  12. The European Consortium on MEN1. Identification of the multiple endocrine neoplasia type 1 (MEN1) gene. Hum Mol Genet 6:1177–1183, 1997.

    Article  Google Scholar 

  13. Debelenko LV, Zhuang Z, Emmert-Buck MR, et al. Allelic deletions on chromosome 11q13 in multiple endocrine neoplasia type 1-associated and sporadic gastrinomas and pancreatic endocrine tumors. Cancer Res 57:2238–2243, 1997.

    PubMed  CAS  Google Scholar 

  14. Dong Q, Debelenko LV, Chandrasekharappa SC, et al. Loss of heterozygosity at 11q13: analysis of pituitary tumors, lung carcinoids, lipomas, and other uncommon tumors in subjects with familial multiple endocrineneoplasia type 1. J Clin Endocrinol Metab 82:1416–1420, 1997.

    Article  PubMed  CAS  Google Scholar 

  15. Abe T, Yoshimoto K, Taniyama M, et al. An unusual kindred of the multiple endocrine neoplasia type 1 (MEN1) in Japanese. J Clin Endocrinol Metab 85:1327–1330, 2000.

    Article  PubMed  CAS  Google Scholar 

  16. Agarwal SK, Kester MB, Debelenko LV, et al. Germline mutations of the MEN1 gene in familial multiple endocrine neoplasia type 1 and related states. Hum Mol Genet 6:1169–1175, 1997.

    Article  PubMed  CAS  Google Scholar 

  17. Bartsch D, Kopp I, Bergenfelz A, et al. MEN1 gene mutations in 12 MEN1 families and their associated tumors. Eur J Endocrinol 139:416–420, 1998.

    Article  PubMed  CAS  Google Scholar 

  18. Bassett JHD, Forbes SA, Pannett AAJ, et al. Characterization of mutations in patients with multiple endocrine neoplasia type 1. Am J Hum Genet 62:232–244, 1998.

    Article  PubMed  CAS  Google Scholar 

  19. Bergman L, Teh B, Cardinal J, et al. Identification of MEN1 gene mutations in families with MEN 1 and related disorders. Br J Cancer 83:1009–1014, 2000.

    Article  PubMed  CAS  Google Scholar 

  20. Burgess JR, Nord B, David R, et al. Phenotype and phenocopy: the relationship between genotype and clinical phenotype in a single large family with multiple endocrine neoplasia type 1 (MEN 1). Clin Endocrinol (Oxf) 53:205–211, 2000.

    Article  CAS  Google Scholar 

  21. Cetami F, Pardi E, Cianferotti L, et al. A new mutation of the MEN1 gene in an Italian kindred with multiple endocrine neoplasia type 1. Eur J Endocrinol 140:429–433, 1999.

    Article  Google Scholar 

  22. Dackiw APB, Cote GJ, Fleming JB, et al. Screening for MEN1 mutations in patients with atypical endocrine neoplasia. Surgery 126:1097–1104, 1999.

    Article  PubMed  CAS  Google Scholar 

  23. Debelenko LV, Brambilla E, Agarwal SK, et al. Identification of MEN1 gene mutations in sporadic carcinoid tumors of the lung. Hum Mol Genet 6:2285–2290, 1997.

    Article  PubMed  CAS  Google Scholar 

  24. Engelbach M, Forst T, Hankeln T, et al. Germline mutations in the MEN1 gene: creation of a new splice acceptor site and insertion of 7 intron nucleotides into the mRNA. Int J Mol Med 4:483–485, 1999.

    PubMed  CAS  Google Scholar 

  25. Giraud S, Zhang CX, Serova-Sinilnikova O, et al. Germ-line mutation analysis in patients with multiple endocrine neoplasia type 1 and related disorders. Am J Hum Genet 63:455–467, 1998.

    Article  PubMed  CAS  Google Scholar 

  26. Görtz B, Roth J, Speel EJM, et al. MEN1 gene mutation analysis of sporadic adrenocortical lesions. Int J Cancer 80:373–379, 1999.

    Article  PubMed  Google Scholar 

  27. Görtz B, Roth J, Krähenmann A, et al. Mutations and allelic deletions of the MEN1 gene are associated with a subset of sporadic endocrine pancreatic and neuroendocrine tumors and not restricted to foregut neoplasms. Am J Pathol 154:429–436, 1999.

    PubMed  Google Scholar 

  28. Hai N, Aoki N, Matsuda A, Mori T, Kosugi S. Germline MEN1 mutations in sixteen Japanese families with multiple endocrine neoplasia type 1 (MEN1). Eur J Endocrinol 141:475–480, 1999.

    Article  PubMed  CAS  Google Scholar 

  29. Hai N, Aoki N, Shimatsu A, Mori T, Kosugi S. Clinical features of multiple endocrine neoplasia type 1 (MEN1) phenocopy without germline MEN1 gene mutations: analysis of 20 Japanese sporadic cases with MEN1. Clin Endocrinol (Oxf) 52:509–518, 2000.

    Article  CAS  Google Scholar 

  30. Hamaguchi K, Nguyen DC, Yanase T, et al. Novel germline mutations of the MEN1 gene in Japanese patients with multiple endocrine neoplasia type 1. J Hum Genet 44:43–47, 1999.

    Article  PubMed  CAS  Google Scholar 

  31. Heppner C, Kester MB, Agarwal SK, et al. Somatic mutation of the MEN1 gene in parathyroid tumours. Nat Genet 16:375–378, 1997.

    Article  PubMed  CAS  Google Scholar 

  32. Kakizawa T, Sakurai A, Ikeo Y, Ueno I, Hashizume K. Novel deletional mutation of the MEN1 gene in a kindred with multiple endocrine neoplasia type 1. Clin Genet 58:61–63, 2000.

    Article  PubMed  CAS  Google Scholar 

  33. Kishi M, Tsukada T, Shimizu S, et al. A large germline deletion of the MEN1 gene in a family with multiple endocrine neoplasia type 1. Jpn J Cancer Res 89:1–5, 1998.

    PubMed  CAS  Google Scholar 

  34. Kishi M, Tsukada T, Shimizu S, et al. A novel splicing mutation (894-9 G → A) of the MEN1 gene responsible for multiple endocrine neoplasia type 1. Cancer Lett 142:105–110, 1999.

    Article  PubMed  CAS  Google Scholar 

  35. Komminoth P. Multiple endocrine neoplasia type 1, sporadic neuroendocrine tumors, and MENIN. Diagn Mol Pathol 8:107–112, 1999.

    Article  PubMed  CAS  Google Scholar 

  36. Martín-Campos JM, Catasús L, Chico A, et al. Molecular pathology of multiple endocrine neoplasia type I: two novel germline mutations and updated classification of mutations affecting MEN1 gene. Diagn Mol Pathol 8:195–204, 1999.

    Article  PubMed  Google Scholar 

  37. Mayr B, Apenberg S, Rothämel T, von zur Mühlen A, Brabant G. Menin mutations in patients with multiple endocrine neoplasia type 1. Eur J Endocrinol 137:684–687, 1997.

    Article  PubMed  CAS  Google Scholar 

  38. Mayr B, Brabant G, von zur Mühlen A. Menin mutations in MEN1 patients. J Clin Endocrinol Metab 83:3004–3005, 1998.

    Article  PubMed  CAS  Google Scholar 

  39. Morelli A, Falchetti A, Martineti V, et al. MEN1 gene mutation analysis in Italian patients with multiple endocrine neoplasia type 1. Eur J Endocrinol 142:131–137, 2000.

    Article  PubMed  CAS  Google Scholar 

  40. Mutch MG, Dilley WG, Sanjurjo F, et al. Germline mutations in the multiple endocrine neoplasia type 1 gene: evidence for frequent splicing defects. Hum Mutat 13:175–185, 1999.

    Article  PubMed  CAS  Google Scholar 

  41. Poncin J, Abs R, Velkeniers B, et al. Mutation analysis of the MEN1 gene in Belgian patients with multiple endocrine neoplasia type 1 and related diseases. Hum Mutat 13:54–60, 1999.

    Article  PubMed  CAS  Google Scholar 

  42. Sakurai A, Shirahama S, Fujimori M, et al. Novel MEN1 gene mutations in familial multiple endocrine neoplasia type 1. J Hum Genet 43:199–201, 1998.

    Article  PubMed  CAS  Google Scholar 

  43. Sato M, Matsubara S, Miyauchi A, et al. Identification of five novel germline mutations of the MEN1 gene in Japanese multiple endocrine neoplasia type 1 (MEN1) families. J Med Genet 35:915–919, 1998.

    PubMed  CAS  Google Scholar 

  44. Schmidt MC, Henke RT, Stangl AP, et al. Analysis of the MEN1 gene in sporadic pituitary adenomas. J Pathol 188:168–173, 1999.

    Article  PubMed  CAS  Google Scholar 

  45. Shimizu S, Tsukada T, Futami H, et al. Germline mutations of the MEN1 gene in Japanese kindred with multiple endocrine neoplasia type 1. Jpn J Cancer Res 88:1029–1032, 1997.

    PubMed  CAS  Google Scholar 

  46. Stratakis CA, Schussheim DH, Freedman SM, et al. Pituitary macroadenoma in a 5-year-old: an early expression of multiple endocrine neoplasia type 1. J Clin Endocrinol Metab 85:4776–4780, 2000.

    Article  PubMed  CAS  Google Scholar 

  47. Tanaka C, Yoshimoto K, Yamada S, et al. Absence of germ-line mutations of the multiple endocrine neoplasia type 1 (MEN1) gene in familial pituitary adenoma in contrast to MEN1 in Japanese. J Clin Endocrinol Metab 83:960–965, 1998.

    Article  PubMed  CAS  Google Scholar 

  48. Teh BT, Kytölä S, Farnebo F, et al. Mutation analysis of the MEN1 gene in multiple endocrine neoplasia type 1, familial acromegaly and familial isolated hyperparathyroidism. J Clin Endocrinol Metab 83:2621–2626, 1998.

    Article  PubMed  CAS  Google Scholar 

  49. Tsukada T, Kishi M, Obara T, Yamaguchi K. An intronic splicing mutation of the MEN1 gene. Int J Cancer 87:305, 2000.

    Article  PubMed  CAS  Google Scholar 

  50. Uchino S, Noguchi S, Sato M, et al. Screening of the MEN1 gene and discovery of germ-line and somatic mutations in apparently sporadic parathyroid tumors. Cancer Res 60:5553–5557, 2000.

    PubMed  CAS  Google Scholar 

  51. Valdés N, Pérez de Nanclares G, et al. Multiple endocrine neoplasia type 1 (MEN1): clinical heterogeneity in a large family with a nonsense mutation in the MEN1 gene (Trp471Stop). Clin Endocrinol (Oxf) 50:309–313, 1999.

    Article  Google Scholar 

  52. Knudson AG. Hereditary cancer: two hits revisited. J Cancer Res Clin Oncol 122:135–140, 1996.

    Article  PubMed  CAS  Google Scholar 

  53. Farnebo F, Teh BT, Kytölä S, et al. Alterations of the MEN1 gene in sporadic parathyroid tumors. J Clin Endocrinol Metab 83:2627–2630, 1998.

    Article  PubMed  CAS  Google Scholar 

  54. Hessman O, Lindberg D, Skogseid B, et al. Mutation of the multiple endocrine neoplasia type 1 gene in nonfamilial, malignant tumors of the endocrine pancreas. Cancer Res 58:377–379, 1998.

    PubMed  CAS  Google Scholar 

  55. Vortmeyer AO, Böni R, Pack SD, Darling TN, Zhuang Z. Perivascular cells harboring multiple endocrine neoplasia type 1 alterations are neoplastic cells in angiofibromas. Cancer Res 59:274–278, 1999.

    PubMed  CAS  Google Scholar 

  56. Zhuang Z, Vortmeyer AO, Pack S, et al. Somatic mutations of the MEN1 tumor suppressor gene in sporadic gastrinomas and insulinomas. Cancer Res 57:4682–4686, 1997.

    PubMed  CAS  Google Scholar 

  57. Zhuang Z, Ezzat SZ, Vortmeyer AO, et al. Mutations of the MEN1 tumor suppressor gene in pituitary tumors. Cancer Res 57:5446–5451, 1997.

    PubMed  CAS  Google Scholar 

  58. Guru SC, Goldsmith PK, Burns AL, et al. Menin, the product of the MEN1 gene, is a nuclear protein. Proc Natl Acad Sci USA 95:1630–1634, 1998.

    Article  PubMed  CAS  Google Scholar 

  59. Larsson C, Shepherd J, Nakamura Y, et al. Predictive testing for multiple endocrine neoplasia type 1 using DNA polymorphisms. J Clin Invest 89:1344–1349, 1992.

    Article  PubMed  CAS  Google Scholar 

  60. Bassett JHD, Rashbass P, Harding B, Forbes SA, Pannett AAJ, Thakker RV. Studies of the murine homolog of the multiple endocrine neoplasia type 1 (MEN1) gene, men1. J Bone Miner Res 14:3–10, 1999.

    Article  PubMed  CAS  Google Scholar 

  61. Ikeo Y, Sakurai A, Suzuki R, et al. Proliferation-associated expression of the MEN1 gene as revealed by in situ hybridization: possible role of the menin as a negative regulator of cell proliferation under DNA damage. Lab Invest 80:797–804, 2000.

    PubMed  CAS  Google Scholar 

  62. Karges W, Maier S, Wissmann A, Dralle H, Dosch HM, Boehm BO. Primary structure, gene expression and chromosomal mapping of rodent homologs of the MEN1 tumor suppressor gene. Biochim Biophys Acta 1446:286–294, 1999.

    PubMed  CAS  Google Scholar 

  63. Maruyama K, Tsukada T, Hosono T, et al. Structure and distribution of rat menin mRNA. Mol Cell Endocrinol 156:25–33, 1999.

    Article  PubMed  CAS  Google Scholar 

  64. Stewart C, Parente F, Piehl F, et al. Characterization of the mouse Men1 gene and its expression during development. Oncogene 17:2485–2493, 1998.

    Article  PubMed  CAS  Google Scholar 

  65. Wautot V, Khodaei S, Frappart L, et al. Expression analysis of endogenous menin, the product of the multiple endocrine neoplasia type 1 gene, in cell lines and human tissues. Int J Cancer 85:877–881, 2000.

    Article  PubMed  CAS  Google Scholar 

  66. Huang SC, Zhuang Z, Weil RJ, et al. Nuclear/cytoplasmic localization of the multiple endocrine neoplasia type 1 gene product, menin. Lab Invest 79:301–310, 1999.

    PubMed  CAS  Google Scholar 

  67. Khodaei S, O’Brien KP, Dumanski J, Wong FK, Weber G. Characterization of the MEN1 ortholog in zebrafish. Biochem Biophys Res Commun 264:404–408, 1999.

    Article  PubMed  CAS  Google Scholar 

  68. Manickam P, Vogel AM, Agarwal SK, et al. Isolation, characterization, expression and functional analysis of the zebrafish ortholog of MEN1. Mamm Genome 11:448–454, 2000.

    Article  PubMed  CAS  Google Scholar 

  69. Maruyama K, Tsukada T, Honda M, et al. Complementary DNA structure and genomic organization of drosophila menin. Mol Cell Endocrinol 168:135–140, 2000.

    Article  PubMed  CAS  Google Scholar 

  70. Rubin GM, Yandell MD, Wortman JR, et al. Comparative genomics of the eukaryotes. Science 287:2204–2215, 2000.

    Article  PubMed  CAS  Google Scholar 

  71. Khodaei-O’Brien S, Zablewska B, Fromaget M, Bylund L, Weber G, Gaudray P. Heterogeneity at the 5′-end of MEN1 transcripts. Biochem Biophys Res Commun 276:508–514, 2000.

    Article  PubMed  CAS  Google Scholar 

  72. Kim YS, Burns AL, Goldsmith PK, et al. Stable overexpression of MEN1 suppresses tumorigenicity of RAS. Oncogene 18:5936–5942, 1999.

    Article  PubMed  CAS  Google Scholar 

  73. Agarwal SK, Guru SC, Heppner C, et al. Menin interacts with the AP1 transcription factor JunD and represses JunD-activated transcription. Cell 96:143–152, 1999.

    Article  PubMed  CAS  Google Scholar 

  74. Gobl AE, Berg M, Lopez-Egido JR, Öberg K, Skogseid B, Westin G. Menin represses JunD-activated transcription by a histone deacetylase-dependent mechanism. Biochim Biophys Acta 1447:51–56, 1999.

    PubMed  CAS  Google Scholar 

  75. Knapp JI, Heppner C, Hickman AB, et al. Identification and characterization of JunD missense mutants that lack menin binding. Oncogene 19:4706–4712, 2000.

    Article  PubMed  CAS  Google Scholar 

  76. Sakurai A, Katai M, Itakura Y, Ikeo Y, Hashizume K. Premature centromere division in patients with multiple endocrine neoplasia type 1. Cancer Genet Cytogenet 109:138–140, 1999.

    Article  PubMed  CAS  Google Scholar 

  77. Tomassetti P, Cometa G, Del Vecchio E, et al. Chromosomal instability in multiple endocrine neoplasia type 1: cytogenetic evaluation with DEB test. Cancer Genet Cytogenet 79:123–126, 1995.

    Article  PubMed  CAS  Google Scholar 

  78. Orita M, Suzuki Y, Sekiya T, Hayashi K. Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics 5:874–879, 1989.

    Article  PubMed  CAS  Google Scholar 

  79. Sarkar G, Yoon HS, Sommer SS. Dideoxy fingerprinting (ddF): a rapid and efficient screen for the presence of mutations. Genomics 13:441–443, 1992.

    Article  PubMed  CAS  Google Scholar 

  80. Fischer SG, Lerman LS. DNA fragments differing by single base-pair substitutions are separated in denaturing gradient gels: correspondence with melting theory. Proc Natl Acad Sci USA 80:1579–1583, 1983.

    Article  PubMed  CAS  Google Scholar 

  81. Powell SM, Petersen GM, Krush AJ, et al. Molecular diagnosis of familial adenomatous polyposis. N Engl J Med 329:1982–1987, 1993.

    Article  PubMed  CAS  Google Scholar 

  82. Pack SD, Zbar B, Pak E, et al. Constitutional von Hippel-Lindau (VHL) gene deletions detected in VHL families by fluorescence in situ hybridization. Cancer Res 59:5560–5564, 1999.

    PubMed  CAS  Google Scholar 

  83. Celi FS, Cohen MM, Antonarakis SE, Wertheimer E, Roth J, Shuldiner AR. Determination of gene dosage by a quantitative adaptation of the polymerase chain reaction (gd-PCR): rapid detection of deletions and duplications of gene sequences. Genomics 21:304–310, 1994.

    Article  PubMed  CAS  Google Scholar 

  84. Bear JC, Briones-Urbina R, Fahey JF, Farid NR. Variant multiple endocrine neoplasia I (MEN IBurin): further studies and non-link-age to HLA. Hum Hered 35:15–20, 1985.

    Article  PubMed  CAS  Google Scholar 

  85. Farid NR, Buehler S, Russell NA, Maroun FB, Allerdice P, Smyth HS. Prolactinomas in familial multiple endocrine neoplasia syndrome type I. Relationship to HLA and carcinoid tumors. Am J Med 69:874–880, 1980.

    PubMed  CAS  Google Scholar 

  86. Olufemi S-E, Green JS, Manickam P, et al. Common ancestral mutation in the MEN1 gene is likely responsible for the prolactinoma variant of MEN1 (MEN1Burin) is four kindreds from Newfoundland. Hum Mutat 11:264–269, 1998.

    Article  PubMed  CAS  Google Scholar 

  87. Wassif WS, Moniz CF, Friedman E, et al. Familial isolated hyperparathyroidism: a distinct genetic entity with an increased risk of parathyroid cancer. J Clin Endocrinol Metab 77:1485–1489, 1993.

    Article  PubMed  CAS  Google Scholar 

  88. Fujimori M, Shirahama S, Sakurai A, et al. Novel V184E MEN1 germline mutation in a Japanese Kindred with familial hyperparathyroidism. Am J Med Genet 80:221–222, 1998.

    Article  PubMed  CAS  Google Scholar 

  89. Honda M, Tsukada T, Tanaka H, et al. A novel mutation of the MEN1 gene in a Japanese kindred with familial isolated primary hyperparathyroidism. Eur J Endocrinol 142:138–143, 2000.

    Article  PubMed  CAS  Google Scholar 

  90. Karges W, Jostarndt K, Maier S, et al. Multiple endocrine neoplasia type 1 (MEN1) gene mutations in a subset of patients with sporadic and familial primary hyperparathyroidism target the coding sequence but spare the promoter region. J Endocrinol 166:1–9, 2000.

    Article  PubMed  CAS  Google Scholar 

  91. Kassem M, Kruse TA, Wong FK, Larsson C, Teh BT. Familial isolated hyperparathyroidism as a variant of multiple endocrine neoplasia type 1 in a large Danish pedigree. J Clin Endocrinol Metab 85:165–167, 2000.

    Article  PubMed  CAS  Google Scholar 

  92. Ohye H, Sato M, Matsubara S, et al. Germline mutation of the multiple endocrine neoplasia type 1 (MEN1) gene in a family with primary hyperparathyroidism. Endocr J 45:719–723, 1998.

    PubMed  CAS  Google Scholar 

  93. Teh BT, Esapa CT, Houlston R, et al. A family with isolated hyperparathyroidism segregating a missense MEN1 mutation and showing loss of the wild-type alleles in the parathyroid tumors. Am J Hum Genet 63:1544–1549, 1998.

    Article  PubMed  CAS  Google Scholar 

  94. Teh BT, Farnebo F, Twigg S, et al. Familial isolated hyperparathyroidism maps to the hyperparathyroidism-jaw tumor locus in 1q21-q32 in a subset of families. J Clin Endocrinol Metab 83:2114–2120, 1998.

    Article  PubMed  CAS  Google Scholar 

  95. Jackson CE, Norum RA, Boyd SB, et al. Hereditary hyperparathyroidism and multiple ossifying jaw fibromas: a clinically and genetically distinct syndrome. Surgery 108:1006–1012, 1990.

    PubMed  CAS  Google Scholar 

  96. Szabó J, Heath B, Hill VM, et al. Hereditary hyperparathyroidism-jaw tumor syndrome: the endocrine tumor gene HRPT2 maps to chromosome 1q21-q31. Am J Hum Genet 56:944–950, 1995.

    PubMed  Google Scholar 

  97. Benlian P, Giraud S, Lahlou N, et al. Familial acromegaly: a specific clinical entity—further evidence from the genetic study of a three-generation family. Eur J Endocrinol 133:451–456, 1995.

    PubMed  CAS  Google Scholar 

  98. Gadelha MR, Prezant TR, Une KN, et al. Loss of heterozygosity on chromosome 11q13 in two families with acromegaly/gigantism is independent of mutations of the multiple endocrine neoplasia type I gene. J Clin Endocrinol Metab 84:249–256, 1999.

    Article  PubMed  CAS  Google Scholar 

  99. Sato M, Miyauchi A, Namihira H, et al. A newly recognized germline mutation of MEN1 gene identified in a patient with parathyroid adenoma and carcinoma. Endocrine 12:223–226, 2000.

    Article  PubMed  CAS  Google Scholar 

  100. Fujii T, Kawai T, Saito K, et al. MEN1 gene mutations in sporadic neuroendocrine tumors of foregut derivation. Pathol Int 49:968–973, 1999.

    Article  PubMed  CAS  Google Scholar 

  101. Stock JL, Warth MR, Teh BT, et al. A kindred with a variant of multiple endocrine neoplasia type 1 demonstrating frequent expression of pituitary tumors but not linked to the multiple endocrine neoplasia type 1 locus at chromosome region 11q13. J Clin Endocrinol Metab 82:486–492, 1997.

    Article  PubMed  CAS  Google Scholar 

  102. Beaudet AL, Tsui L-C. A suggested nomenclature for designating mutations. Hum Mutat 2:245–248, 1993.

    Article  PubMed  CAS  Google Scholar 

  103. Ackermann F, Krohn K, Windgassen M, Buchfelder M, Fahlbusch R, Paschke R. Acromegaly in a family without a mutation in the menin gene. Exp Clin Endocrinol Diabetes 107:93–96, 1999.

    Article  PubMed  CAS  Google Scholar 

  104. Agarwal SK, Debelenko LV, Kester MB, et al. Analysis of recurrent germline mutations in the MEN1 gene encountered in apparently unrelated families. Hum Mutat 12:75–82, 1998.

    Article  PubMed  CAS  Google Scholar 

  105. Emmert-Buck MR, Debelenko LV, Agarwal S, et al. 11q13 allelotype analysis in 27 Northern American MEN1 kindreds identifies two distinct founder chromosomes. Mol Genet Metab 63:151–155, 1998.

    Article  PubMed  Google Scholar 

  106. Padgett RA, Grabowski PJ, Konarska MM, Seiler S, Sharp PA. Splicing of messenger RNA precursors. Ann Rev Biochem 55: 1119–1150, 1986.

    Article  PubMed  CAS  Google Scholar 

  107. Komminoth P. A 5178-9G→ A splice donor site mutation in intron 4 of the men1 gene causing multiple endocrine neoplasia type 1. Int J Cancer 87:306–307, 2000.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology, Kitasato University School of Medicine, Japan

    Toru Kameya MD, PhD

  2. Growth Factor Division, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, 104-0045, Tokyo, Japan

    Toshihiko Tsukada MD, PhD & Ken Yamaguchi MD, PhD

Authors
  1. Toshihiko Tsukada MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ken Yamaguchi MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Toru Kameya MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tsukada, T., Yamaguchi, K. & Kameya, T. The MEN1 gene and associated diseases: An update. Endocr Pathol 12, 259–273 (2001). https://doi.org/10.1385/EP:12:3:259

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1385/EP:12:3:259

Key Words

Search

Navigation